<DOC>
	<DOCNO>NCT00191620</DOCNO>
	<brief_summary>The purpose study determine : How standard gemcitabine plus cisplatin compare fix dose rate gemcitabine plus cisplatin treatment non-small cell lung cancer . The safety standard gemcitabine plus cisplatin side effect might associate compare fix dose rate gemcitabine plus cisplatin .</brief_summary>
	<brief_title>Study Comparing Short Infusion Vs . Fixed Dose Cisplatin + Gemcitabine Non Small Cell Lung Cancer .</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>At least 18 year age Histologically cytologically confirm diagnosis NSCLC Have provide write informed consent Eastern Cooperative Oncology Group ( ECOG ) Performance Status 0 1 Adequate organ function Prior chemotherapy biologic therapy ( approved experimental ) NSCLC Presence uncontrolled central nervous system ( CNS ) metastases Inability comply protocol study procedure Pregnancy Breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>